Document de presse | 2026.04.02
A historic collaboration- the first scientific agreement between the world-renowned Institut Pasteur and the world’s leading beauty company.This strategic partnership brings together their complementary expertise in immunology, microbiology, and beauty science to explore the skin biomarkers and microbiome as well as skin implication in people’s health management.The partnership will...
Article | 2025.09.05
Frequently asked questions about accommodation offered by the Institut Pasteur
News | 2025.12.18
The influenza epidemic is officially under way in France, a little earlier than last year. Every year, the Institut Pasteur monitors respiratory viruses, including influenza. This season it is contributing new expertise, using modeling to forecast the peak of the 2025-2026 outbreak. It is always worth bearing in mind that although seasonal influenza is usually a mild disease, it can also be fatal...
News | 2026.04.21
The Institut Pasteur and OpenAIRE have formalised a strategic collaboration through the signing of a Memorandum of Understanding (MoU) aimed at advancing Open Science training and strengthening research capacity across Europe. The partnership brings together the Institut Pasteur’s leadership in biomedical research, education, and public health with OpenAIRE’s expertise in open scholarly...
Article | 2017.01.06
Develop your expertise through an internship within the Pasteur Network
Article | 2023.04.04
A 4-year Group leaders’ position is open at the Pasteur Fiocruz Center on Immunology and Immunotherapy
Article | 2020.04.17
A distinction to highlight promising and young scientists within the Pasteur Network
Article | 2016.11.17
The Institut Pasteur’s Scientific Council issues an opinion on all issues of scientific policy, organization, and research and teaching program. It must be consulted on the creation, abolition and consolidation of research and teaching structures. It meets at least twice a semester.
News | 2026.04.24
Over time, various vaccine technologies have been developed, all based on the same idea of exposing the body to a weakened pathogen or pathogenic element so that the immune system can learn to recognize and defend against it. We take a look at the principles, advantages and limits of the main types of vaccine currently available.
News | 2025.09.22
A new CRISPR-based RNA test detects animal trypanosomes, which helps track parasites that pose a threat to livestock in Africa and monitor the transmission of human-infectious species. This study was conducted by an international consortium led by the Institut Pasteur. Its outcomes are wholly aligned with both the Institut Pasteur's long-standing mission of fighting infectious disease threats and...